Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
480
datasets available to search
ShareScore release 0.7.1
Dataset results
480 results for “Hormone Receptors”
A Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Hormone Receptor Positive Breast Cancer Patients
ClinicalTrials.gov study NCT06825949. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT06179303. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer
ClinicalTrials.gov study NCT06797635. IPD Sharing: YES. Countries: 4. Publications: 0.
Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Pri
ClinicalTrials.gov study NCT06408168. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer
ClinicalTrials.gov study NCT03024580. IPD Sharing: NO. Countries: 1. Publications: 0.
Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT03359954. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical P
ClinicalTrials.gov study NCT06930859. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy
ClinicalTrials.gov study NCT07137871. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metast
ClinicalTrials.gov study NCT04916509. IPD Sharing: NO. Countries: 3. Publications: 0.
Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT06105008. IPD Sharing: NO. Countries: 1. Publications: 0.
Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer
ClinicalTrials.gov study NCT04460807. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluation of Mammographic Breast Density in Participants with Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
ClinicalTrials.gov study NCT03609021. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) a
ClinicalTrials.gov study NCT07340619. IPD Sharing: NO. Countries: 0. Publications: 0.
Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer
ClinicalTrials.gov study NCT04762979. IPD Sharing: NO. Countries: 1. Publications: 0.
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT03723928. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Investigating Patient Satisfaction With Oral Anti-cancer Treatment in Patients With Hormone-receptor Positive, HER2-receptor Negative, Advanced Breast Cancer
ClinicalTrials.gov study NCT02875951. IPD Sharing: NO. Countries: 1. Publications: 0.
Acupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.
ClinicalTrials.gov study NCT05460819. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT05816655. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Rec
ClinicalTrials.gov study NCT06851442. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiation Therapy and M7824 in Treating Patients With Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT03524170. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.